While they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...

Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...

Sun Pharma, Adani Ports, TechM, UPL, Voltas, Varun Beverages, Chola Finance, UPL, Macrotech Developers, Max Healthcare, Kansai Nerolac and ...

Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used...

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod...

The stock had scaled its record high of Rs 558 on June 12, 2017 and a 52-week low of Rs 329.95 on December 26, 2016.

Here is a list of top stocks that are likely to be in focus in today's session.

"Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Fingolimod capsules, 0.5 mg, the generic version of Gile...

The company has filed Abbreviated New Drug Applications for Fingolimod, 0.5 mg capsules and Cabazitaxel, 60mg/ 1.5ml injection with the USF...